DNA immunization in a mouse model of latent tuberculosis: Effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

Infection and Immunity

Volumn 70, Issue 7, 2002, Pages 3318-3323

  Repique, Charlene J ^a   Li, Amy ^a   Collins, Frank M ^a   Morris, Sheldon L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DEXAMETHASONE; DNA VACCINE; ISONIAZID; RIFAMPICIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; IMMUNOTHERAPY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REINFECTION; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VACCINATION; VACCINES, DNA;

EID: 0036083946     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.7.3318-3323.2002     Document Type: Article

References (29)

1. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
2. Phage type of tubercle bacilli isolated from patients with two or more sites of involvement
3. Simultaneous infections with multiple strains of Mycobacterium tuberculosis
4. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease
5. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates
6. Efficacy of BCG vaccine in the prevention of tuberculosis: Meta analysis of the published literature
7. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
8. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis
9. Effect of vaccines in a murine model of dormant tuberculosis
10. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country
11. Exogenous reinfection in tuberculosis
12. Sterilizing activity of the main drugs on the mouse experimental tuberculosis
13. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences
14. Therapy of tuberculosis in mice by DNA vaccination
15. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues
16. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli
17. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
18. The immunogenicity of single and combination tuberculosis DNA vaccines
19. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
20. Tuberculosis vaccine development: Recent progress
21. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis
22. Reactivation of latent tuberculosis: Variations on the Cornell murine model
23. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon-γ and nitric oxide synthase 2
24. Exogenous reinfection with multidrug-resistant tuberculosis in an immunocompetent patient
25. Heat shock proteins: The 'Swiss Army Knife' vaccines against cancers and infectious agents
26. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode
27. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells
28. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
29. Heat shock proteins, tumor immunogenicity, and antigen presentation: An integrated view